Income Statement PREDILIFE

Stocks

ALPRE

FR0010169920

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-09-25 EDT			5-day change	1st Jan Change
1.025 ^EUR	+9.04%		+0.49%	-65.95%

06-28	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-09	Intégrance Launches Preventive Health Program for Employees

e031738ed54421975ff4ba785.-FHwp0uolX1hdvJ1y8T5DX9J16OFfLiYlf_HN3_6gSw.mSeWlTjK208YOb80v_yuYDkHk_LgFvf18riQDxKO9niUF6DRAtDWMy8UgQ

Published financial data: PREDILIFE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	142K	289K	318K	493K	836K
Other Revenues, Total	-	-	-	-	-
Total Revenues	142K	289K	318K	493K	836K
Cost of Goods Sold, Total	53.42K	44.24K	14.64K	19.92K	19.06K
Gross Profit	88.66K	244K	303K	473K	817K
Selling General & Admin Expenses, Total	2.02M	2.02M	2.21M	2.61M	2.93M
Depreciation & Amortization - (IS)	29.2K	19.09K	18.15K	31.51K	19.52K
Other Operating Expenses	1.56M	1.71M	1.92M	1.83M	1.14M
Other Operating Expenses, Total	3.61M	3.75M	4.15M	4.47M	4.08M
Operating Income	-3.52M	-3.5M	-3.85M	-4M	-3.27M
Interest Expense, Total	-189K	-321K	-626K	-868K	-1.09M
Interest And Investment Income	-	4.66K	14K	760K	75.45K
Net Interest Expenses	-189K	-316K	-612K	-108K	-1.02M
Currency Exchange Gains (Loss)	-426	-	-	-	-
Other Non Operating Income (Expenses)	0	-	-	-	1
EBT, Excl. Unusual Items	-3.71M	-3.82M	-4.46M	-4.11M	-4.28M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Other Unusual Items	900	-90.31K	2.24K	-501K	-
EBT, Incl. Unusual Items	-3.71M	-3.91M	-4.46M	-4.61M	-4.28M
Income Tax Expense	-295K	-256K	-232K	-342K	-348K
Earnings From Continuing Operations	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Net Income to Company	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Net Income - (IS)	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Net Income to Common Incl Extra Items	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Net Income to Common Excl. Extra Items	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Per Share Items
Net EPS - Basic	-0.93	-1	-1.14	-1.13	-1
Basic EPS - Continuing Operations	-0.93	-1	-1.14	-1.13	-1
Basic Weighted Average Shares Outstanding	3.66M	3.65M	3.72M	3.76M	3.93M
Net EPS - Diluted	-0.93	-1	-1.14	-1.13	-1
Diluted EPS - Continuing Operations	-0.93	-1	-1.14	-1.13	-1
Diluted Weighted Average Shares Outstanding	3.66M	3.65M	3.72M	3.76M	3.93M
Normalized Basic EPS	-0.63	-0.65	-0.75	-0.68	-0.68
Normalized Diluted EPS	-0.63	-0.65	-0.75	-0.68	-0.68
Supplemental Items
EBITDA	-3.49M	-3.47M	-3.83M	-3.99M	-3.25M
EBITA	-3.52M	-3.5M	-3.85M	-3.98M	-3.26M
EBIT	-3.52M	-3.5M	-3.85M	-4M	-3.27M
EBITDAR	-3.33M	-3.31M	-3.67M	-3.75M	-3.02M
Total Revenues (As Reported)	196K	315K	331K	499K	854K
Effective Tax Rate - (Ratio)	7.95	6.55	5.21	7.43	8.12
Normalized Net Income	-2.32M	-2.39M	-2.79M	-2.57M	-2.68M
Supplemental Operating Expense Items
Net Rental Expense, Total	166K	159K	167K	232K	229K
Imputed Operating Lease Interest Expense	63.61K	65.51K	113K	260K	382K
Imputed Operating Lease Depreciation	102K	93.57K	53.8K	-28.22K	-153K
Maintenance & Repair Expenses, Total	4.11K	8.03K	5.9K	6.1K	6.31K

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	2.82M	3.73M	2.51M	1.06M	557K
Short Term Investments	94.9K	94.43K	918K	350K	188K
Total Cash And Short Term Investments	2.92M	3.82M	3.43M	1.41M	745K
Accounts Receivable, Total	108K	134K	177K	430K	474K
Other Receivables	603K	562K	629K	172K	531K
Total Receivables	710K	696K	806K	602K	1M
Inventory	8.8K	-	-	-	5.11K
Prepaid Expenses	34.62K	70.68K	-	80.28K	-
Other Current Assets, Total	24.08K	15.3K	-	245K	94
Total Current Assets	3.69M	4.6M	4.23M	2.34M	1.75M
Gross Property Plant And Equipment	347K	190K	205K	88.38K	94.78K
Accumulated Depreciation	-200K	-156K	-168K	-62.29K	-72.82K
Net Property Plant And Equipment	147K	33.64K	36.69K	26.1K	21.96K
Other Intangibles, Total	-	-	21.24K	0	2.97K
Other Long-Term Assets, Total	124K	111K	100K	81.51K	53.8K
Total Assets	3.97M	4.75M	4.39M	2.44M	1.83M
Liabilities
Accounts Payable, Total	179K	247K	336K	420K	782K
Short-term Borrowings	2.83K	896	1.51K	-	-
Current Portion of Long-Term Debt	472K	-	599K	494K	464K
Current Income Taxes Payable	201K	390K	374K	780K	1.91M
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	854K	638K	1.31M	1.69M	3.16M
Long-Term Debt	4.66M	7.34M	6.83M	4.45M	5.06M
Other Non Current Liabilities	20.7K	1.99M	5.34M	9.43M	9.98M
Total Liabilities	5.53M	9.97M	13.48M	15.57M	18.2M
Common Stock, Total	91.51K	91.51K	93.01K	94.06K	98.81K
Additional Paid In Capital	12.73M	-	-	-	-
Retained Earnings	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Comprehensive Income and Other	-10.98M	-1.66M	-4.95M	-8.96M	-12.53M
Total Common Equity	-1.57M	-5.22M	-9.08M	-13.13M	-16.36M
Total Equity	-1.57M	-5.22M	-9.08M	-13.13M	-16.36M
Total Liabilities And Equity	3.97M	4.75M	4.39M	2.44M	1.83M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.65M	3.64M	3.7M	3.75M	3.95M
ECS Total Common Shares Outstanding	3.65M	-	3.7M	3.75M	3.95M
Book Value / Share	-0.43	-1.43	-2.46	-3.5	-4.15
Tangible Book Value	-1.57M	-5.22M	-9.11M	-13.13M	-16.36M
Tangible Book Value Per Share	-0.43	-1.43	-2.46	-3.5	-4.15
Total Debt	5.13M	7.34M	7.43M	4.95M	5.52M
Net Debt	2.21M	3.52M	4M	3.54M	4.78M
Debt Equivalent Oper. Leases	1.33M	1.27M	1.34M	1.85M	1.83M
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	347K	190K	205K	88.38K	94.78K
Full Time Employees	14.49	-	18.66	19.99	20.54

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	-3.41M	-3.65M	-4.22M	-4.26M	-3.93M
Depreciation & Amortization - CF	29.2K	31.93K	12.69K	-89K	10.54K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	13.7K	9.13K
Depreciation & Amortization, Total	29.2K	31.93K	12.69K	-75.3K	19.67K
(Gain) Loss From Sale Of Asset	-	90.56K	-2.24K	102K	-
Other Operating Activities, Total	-	-	1	1	-26.69K
Change in Other Net Operating Assets	-443K	467K	-15.59K	516K	1.38M
Cash from Operations	-3.83M	-3.07M	-4.23M	-3.72M	-2.56M
Capital Expenditure	-3.37K	-26.99K	-42.43K	-5.4K	-2.03K
Sale of Property, Plant, and Equipment	-	34.71K	-	-	-
Investment in Marketable and Equity Securities, Total	-	12.54K	11.08K	18.79K	32.29K
Other Investing Activities, Total	-7.26K	-	-	-701K	10.2K
Cash from Investing	-10.63K	20.26K	-31.36K	-688K	40.46K
Short Term Debt Issued, Total	778	-	617	-	-
Long-Term Debt Issued, Total	2.55M	2.4M	3.6M	3.82M	1.16M
Total Debt Issued	2.55M	2.4M	3.6M	3.82M	1.16M
Short Term Debt Repaid, Total	-	-1.94K	-	-1.51K	-
Long-Term Debt Repaid, Total	-158K	-193K	-96.74K	-2.37M	-
Total Debt Repaid	-158K	-195K	-96.74K	-2.37M	-
Issuance of Common Stock	1.13M	1.76M	360K	269K	730K
Repurchase of Common Stock	-8.63K	-12.37K	-12.86K	-	-
Other Financing Activities, Total	-	-	-800K	500K	130K
Cash from Financing	3.51M	3.95M	3.05M	2.23M	2.02M
Foreign Exchange Rate Adjustments	-865	-4.24K	-3.04K	732K	-
Miscellaneous Cash Flow Adjustments	-	-	-	-1	-
Net Change in Cash	-328K	904K	-1.21M	-1.45M	-503K
Supplemental Items
Levered Free Cash Flow	-2.53M	-2.13M	-2.78M	-2.75M	-1.3M
Unlevered Free Cash Flow	-2.42M	-1.93M	-2.38M	-2.21M	-613K
Change In Net Working Capital	242K	-253K	-49.09K	-369K	-1.41M
Net Debt Issued / Repaid	2.39M	2.21M	3.5M	1.46M	1.16M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	-54.59	-50.28	-52.6	-73.1	-95.48
Return on Total Capital	-62.65	-77.05	-1.03K	50.81	21.47
Return On Equity %	809.21	107.72	59.06	38.4	26.68
Return on Common Equity	809.21	107.72	59.06	38.4	26.68
Margin Analysis
Gross Profit Margin %	62.4	84.67	95.39	95.96	97.72
SG&A Margin	1.42K	701.16	695.53	529.39	350.32
EBITDA Margin %	-2.46K	-1.2K	-1.21K	-808.09	-388.51
EBITA Margin %	-2.48K	-1.21K	-1.21K	-807.88	-389.77
EBIT Margin %	-2.48K	-1.21K	-1.21K	-810.66	-390.86
Income From Continuing Operations Margin %	-2.4K	-1.27K	-1.33K	-864.71	-470.74
Net Income Margin %	-2.4K	-1.27K	-1.33K	-864.71	-470.74
Net Avail. For Common Margin %	-2.4K	-1.27K	-1.33K	-864.71	-470.74
Normalized Net Income Margin	-1.63K	-827.35	-876.83	-520.35	-320.22
Levered Free Cash Flow Margin	-1.78K	-738.89	-873.49	-558.21	-154.97
Unlevered Free Cash Flow Margin	-1.7K	-669.38	-750.33	-448.24	-73.4
Asset Turnover
Asset Turnover	0.04	0.07	0.07	0.14	0.39
Fixed Assets Turnover	0.89	3.2	9.04	15.71	34.79
Receivables Turnover (Average Receivables)	2.05	2.39	2.05	1.62	1.85
Short Term Liquidity
Current Ratio	4.33	7.21	3.23	1.38	0.56
Quick Ratio	4.25	7.08	3.23	1.19	0.55
Operating Cash Flow to Current Liabilities	-4.48	-4.8	-3.23	-2.2	-0.81
Days Sales Outstanding (Average Receivables)	178.18	152.76	178.36	225.24	197.41
Average Days Payable Outstanding	-	-	7.26K	6.95K	-
Long Term Solvency
Total Debt/Equity	-327.72	-140.61	-81.78	-37.68	-33.75
Total Debt / Total Capital	143.91	346.22	-448.87	-60.47	-50.95
LT Debt/Equity	-297.41	-140.6	-75.17	-33.92	-30.92
Long-Term Debt / Total Capital	130.6	346.18	-412.61	-54.44	-46.67
Total Liabilities / Total Assets	139.48	209.97	306.78	637.27	992.53
EBIT / Interest Expense	-18.65	-10.92	-6.14	-4.61	-2.99
EBITDA / Interest Expense	-18.49	-10.82	-6.12	-4.59	-2.98
(EBITDA - Capex) / Interest Expense	-18.51	-10.9	-6.19	-4.6	-2.98
Total Debt / EBITDA	-1.47	-2.11	-1.94	-1.24	-1.7
Net Debt / EBITDA	-0.63	-1.01	-1.04	-0.89	-1.47
Total Debt / (EBITDA - Capex)	-1.47	-2.1	-1.92	-1.24	-1.7
Net Debt / (EBITDA - Capex)	-0.63	-1.01	-1.03	-0.89	-1.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	175.51	103.12	10.11	55.2	69.47
Gross Profit, 1 Yr. Growth %	394.39	175.6	24.06	56.12	72.57
EBITDA, 1 Yr. Growth %	42.23	-0.54	10.41	3.97	-18.53
EBITA, 1 Yr. Growth %	41.54	-0.46	9.76	3.6	-18.52
EBIT, 1 Yr. Growth %	41.54	-0.46	9.76	3.95	-18.29
Earnings From Cont. Operations, 1 Yr. Growth %	51.69	7.05	15.58	0.96	-7.74
Net Income, 1 Yr. Growth %	51.69	7.05	15.58	0.96	-7.74
Normalized Net Income, 1 Yr. Growth %	46.71	2.99	16.7	-7.9	4.29
Diluted EPS Before Extra, 1 Yr. Growth %	45.73	7.22	14	-0.57	-11.78
Accounts Receivable, 1 Yr. Growth %	246.1	24.46	31.86	143.67	10.06
Net Property, Plant and Equip., 1 Yr. Growth %	-14.54	-77.08	9.06	-28.87	-15.86
Total Assets, 1 Yr. Growth %	-3.21	19.71	-7.45	-44.38	-24.98
Tangible Book Value, 1 Yr. Growth %	-316.91	233.46	74.43	44.19	24.64
Common Equity, 1 Yr. Growth %	-316.91	233.46	74.03	44.53	24.62
Cash From Operations, 1 Yr. Growth %	81.49	-19.92	37.98	-12.01	-31.09
Capital Expenditures, 1 Yr. Growth %	-78.51	700.71	57.21	-87.29	-62.34
Levered Free Cash Flow, 1 Yr. Growth %	85.61	-15.84	30.17	-0.82	-52.95
Unlevered Free Cash Flow, 1 Yr. Growth %	80.61	-20.04	23.43	-7.29	-72.25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	149.24	136.56	49.55	30.73	62.17
Gross Profit, 2 Yr. CAGR %	203.42	269.13	84.91	39.17	64.14
EBITDA, 2 Yr. CAGR %	21	18.94	4.79	7.14	-7.96
EBITA, 2 Yr. CAGR %	20.54	18.69	4.53	6.63	-7.97
EBIT, 2 Yr. CAGR %	20.54	18.69	4.53	6.82	-7.84
Earnings From Cont. Operations, 2 Yr. CAGR %	27.43	27.43	11.24	8.03	-3.49
Net Income, 2 Yr. CAGR %	27.43	27.43	11.24	8.03	-3.49
Normalized Net Income, 2 Yr. CAGR %	22.94	22.92	9.63	3.67	-2
Diluted EPS Before Extra, 2 Yr. CAGR %	14.61	25	10.56	6.47	-6.34
Accounts Receivable, 2 Yr. CAGR %	776.78	107.55	28.11	79.25	63.77
Net Property, Plant and Equip., 2 Yr. CAGR %	-11.79	-55.74	-50	-11.93	-22.64
Total Assets, 2 Yr. CAGR %	71.4	7.64	5.26	-28.25	-35.4
Tangible Book Value, 2 Yr. CAGR %	43.12	168.94	141.18	58.59	34.06
Common Equity, 2 Yr. CAGR %	43.12	168.94	140.9	58.59	34.21
Cash From Operations, 2 Yr. CAGR %	26.42	20.56	5.12	10.19	-22.13
Capital Expenditures, 2 Yr. CAGR %	-60.68	31.19	254.79	-55.29	-78.12
Levered Free Cash Flow, 2 Yr. CAGR %	13.13	24.98	4.67	13.62	-31.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	11.19	20.18	-0.65	6.98	-49.28
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	103.39	132.81	83.34	51.41	42.54
Gross Profit, 3 Yr. CAGR %	84.18	193.85	156.64	74.77	49.52
EBITDA, 3 Yr. CAGR %	14.63	13.35	16.02	4.51	-2.21
EBITA, 3 Yr. CAGR %	14.33	13.09	15.64	4.21	-2.4
EBIT, 3 Yr. CAGR %	14.33	13.09	15.64	4.33	-2.31
Earnings From Cont. Operations, 3 Yr. CAGR %	12.92	20.24	23.35	7.7	2.49
Net Income, 3 Yr. CAGR %	12.92	20.24	23.35	7.7	2.49
Normalized Net Income, 3 Yr. CAGR %	14.89	15.89	20.81	3.44	3.88
Diluted EPS Before Extra, 3 Yr. CAGR %	2.74	12.09	21.22	6.72	0
Accounts Receivable, 3 Yr. CAGR %	-	357.38	78.42	58.73	52.35
Net Property, Plant and Equip., 3 Yr. CAGR %	-10.56	-43.71	-40.22	-43.77	-13.26
Total Assets, 3 Yr. CAGR %	19.8	52.07	2.36	-14.9	-27.18
Tangible Book Value, 3 Yr. CAGR %	405.77	89.73	132.8	103.17	46.36
Common Equity, 3 Yr. CAGR %	405.77	89.73	132.62	103.17	46.35
Cash From Operations, 3 Yr. CAGR %	28.38	8.57	26.11	-0.93	-5.77
Capital Expenditures, 3 Yr. CAGR %	-69.44	7.38	39.34	16.97	-57.78
Levered Free Cash Flow, 3 Yr. CAGR %	20.07	2.51	26.69	2.8	-15.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.39	-0.38	21.25	-2.92	-31.78
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	50.47	79.86	84.82	74.56
Gross Profit, 5 Yr. CAGR %	53.3	50.78	84.47	117.92	114.63
EBITDA, 5 Yr. CAGR %	17.22	13.53	10.59	10.82	5.76
EBITA, 5 Yr. CAGR %	17.14	13.32	10.3	10.46	5.55
EBIT, 5 Yr. CAGR %	17.14	13.32	10.3	10.54	5.6
Earnings From Cont. Operations, 5 Yr. CAGR %	18.11	17.17	12.24	15.2	11.82
Net Income, 5 Yr. CAGR %	18.11	17.17	12.24	15.2	11.82
Normalized Net Income, 5 Yr. CAGR %	17.7	14.5	12.76	10.84	11.11
Diluted EPS Before Extra, 5 Yr. CAGR %	8.16	10.76	5.8	9.81	9.34
Accounts Receivable, 5 Yr. CAGR %	-	-	-	214.45	72.41
Net Property, Plant and Equip., 5 Yr. CAGR %	25.5	-9.22	-29.12	-32.67	-33.73
Total Assets, 5 Yr. CAGR %	9.87	36.32	13.76	12.61	-14.85
Tangible Book Value, 5 Yr. CAGR %	33.98	32.21	276.1	76.6	86.69
Common Equity, 5 Yr. CAGR %	33.98	32.21	275.92	76.6	86.68
Cash From Operations, 5 Yr. CAGR %	23.08	14.97	18.52	9.22	3.99
Capital Expenditures, 5 Yr. CAGR %	-43.14	-8.14	-18.51	-24.37	-33.55
Levered Free Cash Flow, 5 Yr. CAGR %	-	14.01	13.65	6.82	-1.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	12.25	10.93	2.5	-14.44